API Holdings, the parent company of online pharmacy PharmEasy, announced last week that it would pick up a 66.1 per cent stake in diagnostics firm Thyrocare for Rs 4,546 crore. It is the first unicorn to acquire a listed company.

• India AI Regulation Paper Due Next Month, Says Vaishnaw
• Cordelia Cruises Operator Posts Rs 54.4 Cr Profit in Q2
• GST Council Plans to Reduce Business Burden
• FII Outflow vs IPO Inflow: What Foreign Investors’ New India Strategy Means for Your Portfolio
• France Faces Rising Student Protests and Debt Concerns 

One of the most extensive consolidations in the domestic health care space, the deal was struck in record time at the Mumbai residence of A Velumani, founder of Thyrocare. The deal is also a milestone for five friends from the Mumbai suburb of Ghatkopar, who called themselves the Ghatkopar Gujju gang and set up PharmEasy in 2015.